NTLA Operating Income - Intellia Therapeutics, Inc.

Complete source-backed operating income history.

Available history: 2015-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$112.76M
2026-03-31	-$100.53M
2025-12-31	-$98.71M
2025-09-30	-$111.48M
2025-06-30	-$110M
2025-03-31	-$120.81M
2024-12-31	-$136.45M
2024-09-30	-$144.77M
2024-06-30	-$139.04M
2024-03-31	-$114M
2023-12-31	-$139.89M
2023-09-30	-$131.11M
2023-06-30	-$132.33M
2023-03-31	-$111.96M
2022-12-31	-$110.09M
2022-09-30	-$105.53M
2022-06-30	-$98.3M
2022-03-31	-$144.25M
2021-12-31	-$80.42M
2021-09-30	-$71.99M
2021-06-30	-$69.02M
2021-03-31	-$46.43M
2020-12-31	-$42.4M
2020-09-30	-$28.1M
2020-06-30	-$33.03M
2020-03-31	-$33.05M
2019-12-31	-$29.77M
2019-09-30	-$25.33M
2019-06-30	-$27.46M
2019-03-31	-$23.81M
2018-12-31	-$20.75M
2018-09-30	-$24.1M
2018-06-30	-$23.6M
2018-03-31	-$22.43M
2017-12-31	-$24.72M
2017-09-30	-$15.88M
2017-06-30	-$16.02M
2017-03-31	-$12.95M
2016-12-31	-$10.82M
2016-09-30	-$7.7M
2016-06-30	-$6.95M
2016-03-31	-$6.69M
2015-12-31	-$5.49M
2015-09-30	-$3.3M
2015-06-30	-$3.42M
2015-03-31	-$1.2M

Annual Operating Income

Date	Operating Income
2025-12-31	-$440.99M
2024-12-31	-$534.26M
2023-12-31	-$515.29M
2022-12-31	-$458.16M
2021-12-31	-$267.85M
2020-12-31	-$136.58M
2019-12-31	-$106.37M
2018-12-31	-$90.87M
2017-12-31	-$69.56M
2016-12-31	-$32.16M
2015-12-31	-$13.41M